- Home
- SNAL vs COYA Comparison
SNAL vs COYA Comparison
Compare SNAL & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAL
- COYA
- Stock Information
- Founded
- SNAL 2000
- COYA 2020
- Country
- SNAL United States
- COYA United States
- Employees
- SNAL N/A
- COYA N/A
- Industry
- SNAL Computer Software: Prepackaged Software
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- SNAL Technology
- COYA Health Care
- Exchange
- SNAL Nasdaq
- COYA Nasdaq
- Market Cap
- SNAL 92.8M
- COYA 98.5M
- IPO Year
- SNAL 2022
- COYA 2022
- Fundamental
- Price
- SNAL $2.36
- COYA $6.20
- Analyst Decision
- SNAL
- COYA Strong Buy
- Analyst Count
- SNAL 0
- COYA 4
- Target Price
- SNAL N/A
- COYA $16.25
- AVG Volume (30 Days)
- SNAL 131.5K
- COYA 49.8K
- Earning Date
- SNAL 11-13-2024
- COYA 03-18-2025
- Dividend Yield
- SNAL N/A
- COYA N/A
- EPS Growth
- SNAL N/A
- COYA N/A
- EPS
- SNAL 0.08
- COYA N/A
- Revenue
- SNAL $86,822,973.00
- COYA $9,554,315.00
- Revenue This Year
- SNAL $39.43
- COYA N/A
- Revenue Next Year
- SNAL $26.12
- COYA $87.80
- P/E Ratio
- SNAL $30.30
- COYA N/A
- Revenue Growth
- SNAL 82.23
- COYA N/A
- 52 Week Low
- SNAL $0.52
- COYA $4.75
- 52 Week High
- SNAL $2.99
- COYA $10.69
- Technical
- Relative Strength Index (RSI)
- SNAL 55.28
- COYA 65.57
- Support Level
- SNAL $1.63
- COYA $5.65
- Resistance Level
- SNAL $2.45
- COYA $5.99
- Average True Range (ATR)
- SNAL 0.39
- COYA 0.34
- MACD
- SNAL -0.03
- COYA 0.09
- Stochastic Oscillator
- SNAL 50.77
- COYA 97.83
About SNAL Snail Inc.
Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.